The United Laboratories International Holdings Limited (HKG:3933)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.60
+0.06 (0.63%)
Apr 28, 2026, 4:08 PM HKT
Market Cap18.82B -30.9%
Revenue (ttm)14.70B -4.0%
Net Income2.32B -21.6%
EPS1.23 -24.4%
Shares Out1.97B
PE Ratio7.75
Forward PE10.73
Dividend0.48 (5.06%)
Ex-Dividend DateJul 7, 2026
Volume4,909,830
Average Volume8,658,212
Open9.53
Previous Close9.54
Day's Range9.44 - 9.71
52-Week Range9.45 - 17.98
Beta0.39
RSI36.26
Earnings DateMay 28, 2026

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin... [Read more]

Sector Healthcare
Founded 1990
Employees 18,000
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3933
Full Company Profile

Financial Performance

In 2025, HKG:3933's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY Financial Statements